Delivery Order SPE2DB20D3101-SPE2DB24FRWF9

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $66K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), provides for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products to the agency. The $4,200.41 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 13, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award is a delivery order valued at $73,566.16 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of ENBREL 50 MG/ML SURECLICKML, a medication, with a completion date of September 24, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,691.18 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024 with a completion date of November 21, 2024. The contract is not designated as a set-aside and was an open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,203.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 21, 2024 with a completion date of August 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,730.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,878.60 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product. The contract has an ultimate completion date of June 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order for ENBREL 50 MG/ML SURECLICKML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,849.91 firm fixed price contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a $11,489.44 firm fixed-price delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ENBREL 50 MG/ML SURECLICK ML. The contract has an ultimate completion date of April 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $56,647.25 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML to the Defense Logistics Agency (DLA). The $27,536.64 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRWF9
    Delivery Order

This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $65,513.16 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 25, 2024, with a completion date of September 26, 2024. The contract is not designated as a set-aside.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 1:33 PM